Abstract:Budd-Chiari syndrome (BCS) is a relatively rare disease, most commonly found in middle-aged females, and is caused by hepatic vein blockage, except in Asian countries where it is more commonly found in males with inferior vena cava (IVC) obstruction.[1] The condition is classified as either primary or secondary depending on the source of the obstruction and whether it originates from within the venous system, such as in thrombosis, or external to the venous system, such as in compression by tumors of adjacent organs or polycystic kidney disease. Primary BCS is the most common manifestation and is most prevalent in those with underlying thrombogenic disorders such as primary myeloproliferative disease, essential thrombocythemia, and myelofibrosis.[2] Conditions that result in hypercoagulability such as pregnancy, oral contraceptive use, factor V mutation, antithrombin deficiency, protein C deficiency, and paroxysmal nocturnal hemoglobinuria can also cause primary BCS.[3] However, in most cases, the local cause of the thrombus formation cannot be identified. BCS generally becomes clinically evident after the occlusion of two or more major hepatic veins ([Figs. 1] and [2]). This causes a build-up of sinusoidal pressure and increased filtration of interstitial fluid into the liver capsule after the capacity of lymphatic drainage capacity has been exceeded. Resulting portal hypertension causes reduced hepatic blood flow and hepatocyte damage.[2] BCS and its progression can range in severity from asymptomatic, unobtrusive disease to acute, debilitating disease with significant morbidity.[4] [5] When symptomatic, BCS can present with abdominal pain and/or distention, ascites, hepatomegaly, jaundice, upper gastrointestinal bleeding, hepatic encephalopathy, and edema.[4] In chronic cases, patients can also present with renal impairment.[1] Article published online: 14 March 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Systemic Amyloidosis Presenting as Budd-Chiari Syndrome: A Case Report

Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report

Budd-Chiari Syndrome Associated With Autoimmune Hemolytic Anemia, Immune Thrombocytopenic Purpura, and Lupus Nephritis: A Case Report

A Nationwide Analysis of Budd-Chiari Syndrome in the United States

Hepatomegaly and jaundice as the presenting symptoms of systemic light-chain amyloidosis: A case report

Budd-Chiari Syndrome: An Unusual Presentation of Multisystemic Sarcoidosis

Hepatic Veno-Occlusive Disease May Be a Rare Characteristic of Hepatic Involvement in Systemic Amyloidosis: Case Report and Literature Review

The Clinical Characteristics of 151 Cases of Budd-Chiari Syndrome

S4275 Triple Risk Factors for Budd-Chiari Syndrome

S4263 Budd-Chiari Plus a Friend - A Case of Chronic Budd Chiari Syndrome and Simultaneous Superior Mesenteric Vein Thrombus

Clinical profile and outcomes of hepatocellular carcinoma in primary Budd-Chiari syndrome

Axillary Lymphadenopathy as an Initial Presentation of Systemic Amyloidosis: A Case Report and Literature Review

Point-of-care ultrasound in the diagnosis and treatment of Budd-Chiari syndrome: A rare case report and literature review

S5059 A Rare Case of Initial Diagnosis of Systemic AL Amyloidosis via Gastric Biopsies

A case of antiphospholipid syndrome presenting cryptogenically as Budd-Chiari syndrome, then fulminantly as Libman-Sacks endocarditis

Liver cirrhosis caused by chronic Budd–Chiari syndrome

Hepatocellular carcinoma as a complication of chronic Budd-Chiari syndrome (BCS) in a child

Advanced Imaging Techniques Used in Direct Portosystemic Shunt Creation in Budd-Chiari Syndrome with Complex Venous Anatomy

Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis

[Budd-Chiari syndrome: a rare complication of hepatic sarcoidosis (about one case)]

Interventions in Budd-Chiari syndrome: an updated review